Alzheimer's Treatment-Alzheimer's Research-Alzheimer's neurotransmitter optimization

Real treatment of Alzheimer's, where brain function is truly restored and is controlled, has eluded medicine. The NeuroResearch Clinics treatment approach produces excellent results in Alzheimer's patients suffering from .

Alzheimer's

The NeuroResearch Clinics approach in treatment of Alzheimer's patients with involves neurotransmitter optimization of the master neurotransmitters of the brain serotonin, dopamine, norepinephrine and epinephrine. These neurotransmitters directly and indirectly control virtually every function in the brain and body. NeuroResearch Clinics uses 5-HTP, tyrosine, levodopa, and cysteine guided by neurotransmitter testing as indicted to restore brain function and get other symptoms associated with Alzheimer's under control. Most Alzheimer's patients show significant improvement of cognitive brain function. 15% to 20% of Alzheimer's patients with achieve profound restoration of brain function. Please, read the case studies in the right brown colored column, these were written by medical doctors (MDs) based on medical care experiences. Restoration of the brain in Alzheimer's patients suffer from neurotransmitter optimization is in a league of its own, beyond results seen with any prescription drug in the past.

Its no secret, NeuroResearch Clinics uses the nutrients 5-HTP, tyrosine, levodopa, and cysteine to treat medical patients in order to get these results. Proper use of these simple ingredients in medical treatment is not simple. From time to time a patient will say, "Why do I want to take that, I can go to a health food store and buy it?" People off the street buying in a health food store is like going to an art store and buying a bunch of oil paints then going home and expecting to paint like a mater artist even though there was no previous painting experience. These nutrients have tremendous potential due to their chemical properties. This potential is only fully realized in the hands of the trained professional using neurotransmitter testing. Treatment is not just giving a nutrient pill, it is the whole medical management approach doctors are trained in to insure that that treatment is on track in order to get symptoms under control.

- Alzheimer's home page

- Case study #1

- Case study #2

- Case study #3

Alzheimer's

SYMPTOMS

While deterioration of brain function takes the spot light in Alzheimer's patient suffering from there are many other problems that can be active, including:

Sleep patterns, Many Alzheimer's patients with suffer from abnormal sleep patterns, up during the night wandering around or sleeping during the day. With serotonin and dopamine optimization normal sleep patterns are restored in the Alzheimer's patient.
Inappropriate anger, aggression, or yelling out, is a problem with some Alzheimer's suffering from . With serotonin and dopamine optimization inappropriate anger, aggression, or yelling out are controlled in the patient.
Agitation, many Alzheimer's patients with suffer from inappropriate agitation. This may take the form of mental or physical agitation. With serotonin and dopamine optimization agitation is controlled in the patient.
Depression is common in Alzheimer's patients with . Depression may display as an agitated depression. In medicine there is no drug that effectively controls depression in the elderly, with or without Alzheimer's . With neurotransmitter optimization of serotonin and dopamine guided by neurotransmitter testing when indicated depression is controlled.
Anxiety, may be present. With neurotransmitter optimization of serotonin and dopamine guided by neurotransmitter testing as indicted, anxiety in the Alzheimer's patient with may be controlled.
Psychotic state is a significant problem with patients talking about and hearing or seeing things that are not there. With neurotransmitter optimization of serotonin and dopamine guided by neurotransmitter testing as indicated, the Alzheimer's patient with may experience control of inappropriate perceptions.
Restless Leg Syndrome is common, contributing greatly sleep disturbance which leads to exacerbation of cognitive problems. With neurotransmitter optimization of serotonin and dopamine guided by neurotransmitter testing as indicted, Restless Leg Syndrome in the Alzheimer's patient with can be controlled.

The Peer Reviewed Research of NeuroResearch Clinics

The neurotransmitter treatment research findings of NeuroResearch Clinics have not been ignored. The University of Minnesota Medical School is writing a series of papers on the neurotransmitter testing research of NeuroResearch Clinics. The first of a series of papers by University of Minnesota Medical School based on the neurotransmitter testing research of NeuroResearch was published in "The Journal of NeuroPsychiatry" May 1, 2009. Ingrid Kohlstadt, MD of Johns Hopkins in her new medical text book released February 7, 2009 included a chapter on depression written by Marty L. Hinz, MD President Clinical Research NeuroResearch Clinics outlining in depth the proper use of amino acids and neurotransmitter testing in treatment of depression.

University of Minnesota Medical School neurotransmitter testing paper on the research of NeuroResearch Clinics.

The medical text book chapter on depression written by Marty L. Hinz, MD-Ingrid Kohlstadt, MD editor-Johns Hopkins released February, 7, 2009

Alzheimer's

WHAT CAUSES

Alzheimer's ?

Elevation of neurotransmitter levels, guided by neurotransmitter testing, reveals excellent results in Alzheimer's patients suffering with . Review of neurotransmitter testing prior to treatment reveals that patients with Alzheimer's , as a group, have virtually the same neurotransmitter levels as those that do not. Therefore low levels of neurotransmitters is not the cause of Alzheimer's .

The primary cause of Alzheimer's appears to be brain damage. The leading cause is neurotoxic damage. Just as with Parkinson's Disease patients elevating neurotransmitter levels restores flow of electricity in the brain compensating for brain damage, restoring normal function, and relieving symptoms.

Alzheimer's Links

Alzheimer's organization

Alzheimer's Medline

Alzheimer's Mayo

Alzheimer's Foundation

Alzheimer's news

If you ne ed a medical speaker for AMA Category I CME ca ll Ne ur oR es earch Clini cs, Inc.

Ne ur oR es earch Clinics, Inc. only deals with and provides information to licensed health care professionals.

care disease diseases patient patients dementia Alzheimer disease disease treatment disease treatments Patient1 patients1 heimers cares care's dementias dementia's ErsDisease Er'sDisease Er'sDiseases ErsTreatment ErsTreatments Er'sTreatment Er'sTreatments ErsPatient ErsPatients Er'sPatients ErsPatient ErsDiseases ErDiseases

keyz keyb

Alzheimer's